AnnMarie Liapakis - Concepedia

Author

AnnMarie Liapakis

Also Known As

A. Liapakis, Ann Marie Liapakis, AnnMarie H. Liapakis, AnnMarie Liapakis, Annmarie H. Liapakis, Annmarie Liapakis, Hyosun Han, Terrault, Norah A.

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Yale University University of California, San Francisco University of Chicago University of Alabama at Birmingham Columbia University

About

AnnMarie Liapakis is an author at Yale University specializing in medicine, virology, and viral hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	784
2	Hepatology	2	2	50
3	Public Health	1	1	39
4	Epidemiology	1	1	663
5	Health Policy	1	1	39

AnnMarie Liapakis

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study David Roth, David R. Nelson, Annette Bruchfeld, The Lancet Hepatic DisordersHepatitis CViral HepatitisChronic Kidney DiseaseCombination Phase 3	2015	663
The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation Josh Levitsky, Richard N. Formica, Roy D. Bloom, American Journal of Transplantation	2017	318
Safety and efficacy of sofosbuvir‐containing regimens in hepatitis C‐infected patients with impaired renal function Varun Saxena, Farrukh M. Koraishy, Meghan E. Sise, Liver International	2016	297
Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade Albert Do, Yash Mittal, AnnMarie Liapakis, PLoS ONE	2015	65
LP08 : Safety and efficacy of sofosbuvir-containing regimens in hepatitis C infected patients with reduced renal function: Real-world experience from HCV-target Varun Saxena, Farrukh M. Koraishy, Meghan E. Sise, Journal of Hepatology HepatologyHepatitis CReal-world ExperienceViral HepatitisAntiviral Therapy	2015	40
Equitable Access to Liver Transplant: Bridging the Gaps in the Social Determinants of Health Russell Rosenblatt, Hannah Lee, AnnMarie Liapakis, Hepatology Organ DonationHealth Care DisparitySocial DeterminantsHealth DisparitiesSocial Determinants Of Health	2021	39
LP02 : C-surfer: grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease David Roth, David R. Nelson, Annette Bruchfeld, Journal of Hepatology Hepatitis CMedicineViral HepatitisAntiviral Drug DevelopmentAntiviral Therapy	2015	32
Advancing diagnosis and management of liver disease in adults through exome sequencing Melanie Zheng, Aaron Hakim, Chigoziri Konkwo, EBioMedicine	2023	27
Variation in adult living donor liver transplantation in the United States: Identifying opportunities for increased utilization Krista L. Lentine, Tomohiro Tanaka, Huiling Xiao, Clinical Transplantation	2023	23
Practice patterns of the medical evaluation of living liver donors in the United States Whitney E. Jackson, Alyson Kaplan, Jessica L. Saben, Liver Transplantation	2022	18

Page 1